Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK

Abroad (travel likely)RecruitingPHASE2

Conditions

Triple-negative Breast Cancer · TNBC - Triple-Negative Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Tumor Zentrum Aarau, Aarau, Switzerland

  • St. Claraspital, Basel, Switzerland

    Contact: Study coordinator (Corinne Cescato, MD) · Corinne.Cescato-Wenger@claraspital.ch · +41 61 685 83 67
    Contact: Principal Investigator (Thomas Schmid, MD)
  • EOC - IOSI Ospedale regionale Bellinzona e valli - San Giovanni, Bellinzona, Switzerland

    Contact: Study coordinator (Lorenzo Rossi, MD) · lorenzo.rossi@eoc.ch · +41 91 811 85 77
    Contact: Principal Investigator (Lorenzo Rossi, MD)
  • Kantonsspital Graubünden, Chur, Switzerland

    Contact: Study coordinator (Michael Schwitter, MD) · michael.schwitter@ksgr.ch · +41 81 256 75 68
    Contact: Principal Investigator (Michael Schwitter, MD)
  • Kantonsspital Baselland, Liestal, Switzerland

    Contact: Study coordinator (Marcus Vetter, MD) · marcus.vetter@ksbl.ch · +41 61 925 2715
    Contact: Principal Investigator (Marcus Vetter, MD)
  • HOCH Health Ostschweiz, Sankt Gallen, Switzerland

    Contact: Study coordinator (Markus Jörger, MD) · markus.joerger@h-och.ch · +41 76 559 10 70
    Contact: Principal Investigator (Markus Jörger, MD)
  • TBZO - Tumor- & Brustzentrum Ostschweiz, Sankt Gallen, Switzerland

  • Kantonsspital Winterthur, Winterthur, Switzerland

    Contact: Study coordinator (Ursina Zürrer, MD) · ursina.zuerrer@ksw.ch · +41 52 266 25 83
    Contact: Principal Investigator (Ursina Zürrer, MD)
  • Universitätsspital Zürich - Klinik für Gynäkologie, Zurich, Switzerland

    Contact: Study coordinator (Isabell Witzel, Prof) · isabell.witzel@usz.ch · +41 43 253 64 05
    Contact: Principal Investigator (Isabell Witzel, Prof)
Study leads
  • Markus Joerger, Prof

    Study Director

    HOCH Health Ostschweiz - Kantonsspital St. Gallen

  • Ursina Zürrer, MD

    Study Chair

    Kantonsspital Winterthur KSW